Dr. Sébastien Renouf has almost 20 years of experience in Regulatory Affairs, Risk Management, Quality Assurance, and Safety Control for Cell & Gene Therapy.  Before joining PathoQuest, Dr. Renouf was Chief Pharmaceutical officer at CELLforCURE a CDMO specialized in the CART Cells manufacturing part of the Novartis Group, where he supported the implementation of inspection and marketing authorization accreditation processes. Prior to the above, as Qualified Person and Deputy CEO, he helped IDM Pharma for the FDA pre-approval inspection, a first in France for innovative therapies.

Dr. Renouf has a Pharmacy degree from Paris XI University and is a Therapeutic Biotechnology graduate from Paris VII University and an internship of the Ile-de-France region with an Industrial and Biomedical Pharmacy specialty.